Skip to content

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01853605
Enrollment
3811
Registered
2013-05-15
Start date
2003-04-30
Completion date
2014-08-31
Last updated
2015-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Augmentation, Breast Implant Revision, Breast Reconstruction

Brief summary

Post-approval study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (Styles 410 FM, FF, MM, or MF) for breast augmentation, reconstruction, or revision

Interventions

DEVICEAnatomically shaped silicone gel-filled breast implants

Surgical implant

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For entry in this study, subjects must have been enrolled in the 410 CA Clinical Study or 410 CARE Clinical Study under the inclusion criteria listed below and received NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants Styles 410 FM, FF, MM, or MF in 1 (for unilateral breast reconstruction or revision) or both breasts. * Female, age 18 or older * Present with one or more of the following conditions: * Primary breast augmentation (i.e., no previous breast implant surgery) indicated for subject dissatisfaction, with size or shape of breast (e.g., mammary hypoplasia), asymmetry, ptosis, or aplasia * Primary breast reconstruction (i.e., no previous breast implant surgery other than implantation of tissue expanders or contralateral augmentation for asymmetry) indicated, in the affected breast, for mastectomy for cancer, prophylactic mastectomy, or breast trauma (resulting in mastectomy) and for the unaffected breast, contralateral asymmetry (may be performed on the date of the mastectomy or the date when permanent implants are placed in the reconstructed breast) * Breast implant revision surgery (i.e., removal and replacement of breast implants) indicated for previous augmentation or reconstruction with silicone-filled or saline-filled breast implants * Has adequate tissue available to cover implants * Willing to undergo MRI at the specified follow-up visit for subjects at MRI designated sites and be eligible for MRI (e.g., no implanted metal or metal devices, no history of severe claustrophobia)

Exclusion criteria

For entry in this study, subjects must have been enrolled in the 410 CA Clinical Study or 410 CARE Clinical Study and met the

Design outcomes

Primary

MeasureTime frameDescription
Subject Satisfaction With Breast Implants on a 5-Point Scale5 yearsSubject satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for subject's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the subject reports different responses for the left and right breasts.
Investigator Satisfaction With Breast Implants on a 5-Point Scale5 yearsInvestigator satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for Investigator's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the Investigator reports different responses for the left and right breasts.
Local Complications5 yearsLocal complications are the cumulative complications occurring in at least 5% of subjects in 1 or more cohorts over the duration of the study. The Kaplan-Meier risk rate is presented.

Countries

United States

Participant flow

Recruitment details

The study was discontinued following product approval.

Participants by arm

ArmCount
Augmentation
Women undergoing breast augmentation.
1,939
Revision-Augmentation
Women undergoing revision of previous breast augmentation.
693
Reconstruction
Women undergoing breast reconstruction.
751
Revision-Reconstruction
Women undergoing revision of previous breast reconstruction.
428
Total3,811

Baseline characteristics

CharacteristicAugmentationRevision-AugmentationReconstructionRevision-ReconstructionTotal
Age, Continuous36.0 Years
STANDARD_DEVIATION 8.65
46.2 Years
STANDARD_DEVIATION 9.96
49.8 Years
STANDARD_DEVIATION 10.03
53.5 Years
STANDARD_DEVIATION 9.11
42.5 Years
STANDARD_DEVIATION 11.52
Sex: Female, Male
Female
1939 Participants693 Participants751 Participants428 Participants3811 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 1,9390 / 6930 / 7510 / 428
serious
Total, serious adverse events
0 / 1,9390 / 6930 / 7510 / 428

Outcome results

Primary

Investigator Satisfaction With Breast Implants on a 5-Point Scale

Investigator satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for Investigator's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the Investigator reports different responses for the left and right breasts.

Time frame: 5 years

Population: Evaluable population: all enrolled subjects implanted with the NATRELLE 410 original style implants, who completed the 5 year follow-up visit, and had data at the time point.

ArmMeasureGroupValue (NUMBER)
AugmentationInvestigator Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied1798 Subjects
AugmentationInvestigator Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied97 Subjects
Revision-AugmentationInvestigator Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied83 Subjects
Revision-AugmentationInvestigator Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied560 Subjects
ReconstructionInvestigator Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied564 Subjects
ReconstructionInvestigator Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied141 Subjects
Revision-ReconstructionInvestigator Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied310 Subjects
Revision-ReconstructionInvestigator Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied83 Subjects
Primary

Local Complications

Local complications are the cumulative complications occurring in at least 5% of subjects in 1 or more cohorts over the duration of the study. The Kaplan-Meier risk rate is presented.

Time frame: 5 years

Population: Evaluable population: all enrolled subjects implanted with the NATRELLE 410 original style implants who completed the 5 year follow-up visit.

ArmMeasureGroupValue (NUMBER)
AugmentationLocal ComplicationsAsymmetry0.83 Percentage of Subjects
AugmentationLocal ComplicationsCapsular Contracture3.27 Percentage of Subjects
Revision-AugmentationLocal ComplicationsCapsular Contracture6.33 Percentage of Subjects
Revision-AugmentationLocal ComplicationsAsymmetry0.87 Percentage of Subjects
ReconstructionLocal ComplicationsAsymmetry5.94 Percentage of Subjects
ReconstructionLocal ComplicationsCapsular Contracture6.48 Percentage of Subjects
Revision-ReconstructionLocal ComplicationsAsymmetry3.32 Percentage of Subjects
Revision-ReconstructionLocal ComplicationsCapsular Contracture7.29 Percentage of Subjects
Primary

Subject Satisfaction With Breast Implants on a 5-Point Scale

Subject satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for subject's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the subject reports different responses for the left and right breasts.

Time frame: 5 years

Population: Evaluable population: all enrolled subjects implanted with the NATRELLE 410 original style implants, who completed the 5 year follow-up visit, and had data at the time point.

ArmMeasureGroupValue (NUMBER)
AugmentationSubject Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied1772 Subjects
AugmentationSubject Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied119 Subjects
Revision-AugmentationSubject Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied87 Subjects
Revision-AugmentationSubject Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied559 Subjects
ReconstructionSubject Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied542 Subjects
ReconstructionSubject Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied145 Subjects
Revision-ReconstructionSubject Satisfaction With Breast Implants on a 5-Point ScaleDefinitely Satisfied295 Subjects
Revision-ReconstructionSubject Satisfaction With Breast Implants on a 5-Point ScaleSomewhat Satisfied89 Subjects

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026